Chiral (Asymmetric) Ligand for Pharmaceutical Synthesis market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.65 billion by 2034, exhibiting a remarkable CAGR of 8.7% during the forecast period.
Chiral (asymmetric) ligands represent specialized molecules engineered to coordinate with metal centers in catalytic systems, enabling the selective production of one...